| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |